Agencyrazorfishhealth.comRazorfish Health
Formerly: Razorfish Healthware
- Kind
- Health network
- Parent
- Publicis Groupe (Publicis Health)
- Country
- US
- Website
- https://www.razorfishhealth.com/
- Clients
- GSK
Campaigns (1)
| Campaign | Client | Year | Topic | Role |
|---|---|---|---|---|
| Cut Short (RSV awareness) lead Adult RSV disease-awareness TV, Pharma TV winner at the 2024 Fierce Pharma Marketing Awards ("Cut Short | RSV Awareness Campaign - Razorfish Health & GSK"). GSK-funded around the Arexvy vaccine launch; whether it is fully unbranded was not confirmed. Pharma disease awareness, not public-sector work. | GSK | 2024 | Vaccination | Creative |
Research notes
Philadelphia-based; still operating under its own brand: a 4 Sept 2025 release on its site calls it "a Publicis Health company", and the site is live (checked 2026-10-22). It was not folded into Digitas Health or Publicis Health, contrary to an earlier note. History (search snippets only, not fetched): launched 2010 as Razorfish Healthware; merged with Rosetta's US health business in 2015 under the Razorfish Health name. The site has no case-study pages (WORK is an on-page anchor), so no caseStudiesUrl. No nonprofit or public-health campaigns found; the only verified credit is GSK-funded disease awareness. Unverified (search snippets only): "The Other TD" (tardive dyskinesia, Neurocrine; likely branded). Credits checked 2026-10-22 against fetched pages: Cut Short (Fierce Pharma Marketing Awards winners page).
Sources
Record agencies/razorfish-health.json, updated 2026-10-22